account_balance
Investment manager · 13F filer · SEC CIK 1047859
Paragon Associates & Paragon Associates II Joint Venture
Reported value$73.6Mas of Mar 31, 2026
Positions14
Top 10 weight90.0%CDE alone is 17%
FiledMay 1545 days after quarter end
Portfolio · as of Mar 31, 2026
Where the money is
CDECoeur MNG Inc
16.6%
SPYState STR SPDR S&P 500 ETF T
13.3%
CDNACaredx Inc
11.8%
DMACDiamedica Therapeutics Inc
8.1%
NVGSNavigator Hldgs Ltd
7.9%
NPKINPK International Inc
7.4%
Sunopta Inc
7.1%
AEMAgnico Eagle Mines Ltd
6.9%
WESWestern Midstream Partners L
5.6%
EPSNEpsilon Energy Ltd
5.4%
IAUXI-80 Gold Corp
5.2%
PROF2.4%CDECoeur MNG Inc
16.6%
SPYState STR SPDR S&P 500 ETF T
13.3%
CDNACaredx Inc
11.8%
DMACDiamedica Therapeutics Inc
8.1%
NVGSNavigator Hldgs Ltd
7.9%
NPKI7.4%Sunopta Inc7.1%
AEM6.9%WES5.6%EPSN5.4%IAUX5.2%PROFBoxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
CDE Coeur MNG Inc 16.6% SPY State STR SPDR S&P 500 ETF T 13.3% CDNA Caredx Inc 11.8% DMAC Diamedica Therapeutics Inc 8.1% NVGS Navigator Hldgs Ltd 7.9% NPKI NPK International Inc 7.4%
Sunopta Inc 7.1%
AEM Agnico Eagle Mines Ltd 6.9% WES Western Midstream Partners L 5.6% EPSN Epsilon Energy Ltd 5.4% IAUX I-80 Gold Corp 5.2% PROF Profound Med Corp 2.4%